Brandinium

Trademark search for:

EYED PHARMA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-08-16 — Application filed
  • 2016-10-17 — Sn assigned for sect 66a appl from ib
  • 2016-10-18 — Application filed
  • 2016-10-22 — Application filed
  • 2016-11-29 — Assigned to examiner
  • 2016-11-30 — Final disposition recorded
  • 2016-12-01 — Office action issued
  • 2016-12-01 — Office action issued
  • 2016-12-01 — Office action issued
  • 2016-12-17 — Office action issued
  • 2017-05-03 — Office action issued
  • 2017-05-03 — Correspondence received in law office
  • 2017-05-03 — Teas/email correspondence entered
  • 2017-05-09 — Notification of letter of suspension e-mailed
  • 2017-05-09 — Suspension letter written
  • 2017-05-09 — Letter of suspension e-mailed
  • 2017-06-15 — Letter of suspension e-mailed
  • 2017-06-15 — Notification of letter of suspension e-mailed
  • 2017-06-15 — Suspension letter written
  • 2017-12-22 — Teas response to suspension inquiry received
  • 2018-01-10 — Assigned to lie
  • 2018-01-11 — Correspondence received in law office
  • 2018-01-11 — Teas/email correspondence entered
  • 2018-01-19 — Approved for pub - principal register
  • 2018-02-07 — Notice of start of opposition period created, to be sent to ib
  • 2018-02-07 — Notification of notice of publication e-mailed
  • 2018-02-07 — Notification of possible opposition sent to ib
  • 2018-02-23 — Notification processed by ib
  • 2018-02-27 — Published for opposition
  • 2018-02-27 — Official gazette publication confirmation e-mailed
  • 2018-03-14 — Notification of possible opposition created, to be sent to ib
  • 2018-03-14 — Notification of possible opposition sent to ib
  • 2018-03-30 — Notification of possible opposition - processed by ib
  • 2018-05-15 — Registered-principal register
  • 2018-08-15 — Final disposition recorded
  • 2018-08-23 — Final disposition recorded
  • 2018-08-23 — Final disposition recorded
  • 2018-09-14 — Final disposition recorded
  • 2019-09-05 — New representative at ib received
  • 2020-01-07 — Teas change of correspondence received
  • 2020-01-16 — Teas change of correspondence received
  • 2020-09-04 — New representative at ib received
  • 2023-01-01 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-01-01 — Attorney/dom.rep.revoked and/or appointed
  • 2023-01-01 — Teas change of correspondence received
  • 2023-01-01 — Teas change of domestic representatives address
  • 2023-05-15 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2023-06-03 — New representative at ib received
  • 2023-07-18 — New representative at ib received
  • 2024-11-29 — Cancelled section 71
  • 2024-11-29 — Final status recorded
  • 2025-07-29 — Total invalidation of reg ext protection created

Owner Information

Eyed Pharma, S.A.
BE
Eyed Pharma, S.A.
BE
Eyed Pharma, S.A.
BE

Correspondent

Clifford D. Hyra Fresh IP PLC
11710 Plaza America Dr., Ste 2000
RESTON, VA 20190
UNITED STATES

Filing Details

Filing Date:
2016-08-16
Status Date:
2024-11-29
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.